Logo image
Orthotopic Ferret Tracheal Transplantation Using a Recellularized Bioengineered Graft Produces Functional Epithelia
Journal article   Open access   Peer reviewed

Orthotopic Ferret Tracheal Transplantation Using a Recellularized Bioengineered Graft Produces Functional Epithelia

Albert C. Pai, Anthony M. Swatek, Thomas J. Lynch, Bethany A. Ahlers, Vitaly Ievlev, John F. Engelhardt and Kalpaj R. Parekh
Bioengineering (Basel), Vol.10(7), 777
06/29/2023
DOI: 10.3390/bioengineering10070777
PMCID: PMC10376427
PMID: 37508804
url
https://doi.org/10.3390/bioengineering10070777View
Published (Version of record) Open Access

Abstract

Tracheal grafts may be necessary to bridge long-segment defects after curative resection for airway obstructions. Bioengineered grafts have emerged as an appealing option, given the possibilities of altering the histologic and cellular profile of the conduit. We previously designed a bioreactor capable of luminally decellularizing and recellularizing a ferret trachea with surface airway epithelia (SAE) basal cells (BCs), and we sought to assess the fate of these grafts when transplanted in an orthotopic fashion. As adjuncts to the procedure, we investigated the use of a vascular endothelial growth factor (VEGF)-laden hydrogel and of immunosuppression (IS) in graft revascularization and viability. IS was shown to limit early graft revascularization, but this effect could be counteracted with VEGF supplementation. Submucosal gland (SMG) loss was shown to be inevitable regardless of the revascularization strategy. Lastly, the bioengineered tracheas survived one month after transplant with differentiation of our implanted BCs that then transitioned into a recipient-derived functional epithelium. The work presented in this manuscript has important implications for future cellular and regenerative therapies.

Details

Metrics

Logo image